Innosuisse Innovation Project Grant 2019

---

April 11, 2019

Innosuisse approved a grant for SunRegen Healthcare AG’s innovation project (Innosuisse funding application no. 35796.1 IP-LS). The total value of this project is CHF 1 million to facilitate the collaboration with EPFL and UZH

This funding supports groundbreaking research and development in healthcare technologies. SunRegen Healthcare AG is committed to improving patient outcomes through innovative solutions. The collaboration with top Swiss universities ensures that the project meets the highest standards of scientific research. The grant enables us to expand our research team, access advanced laboratories, and accelerate the development of new therapies.

Learn more about Innosuisse, the Swiss Innovation Agency that funds innovative projects in healthcare and other industries. Collaborating institutions like EPFL and University of Zurich (UZH) play a key role in research and development.

Read more about our other innovation projects and how SunRegen Healthcare AG is advancing medical research. Check our company profile to learn more about our mission and collaborations.

The Innosuisse Innovation Grant 2019 allows SunRegen to focus on pioneering solutions that could transform patient care. Our multidisciplinary team works closely with researchers and clinicians to ensure the project delivers tangible results. By leveraging the latest technologies and methodologies, we aim to contribute to the global healthcare community and support sustainable medical advancements.

This grant also fosters knowledge exchange, allowing our team to gain insights from academic experts and implement innovative techniques in real-world healthcare settings. The project emphasizes collaboration, innovation, and excellence, aligning with SunRegen Healthcare AG’s long-term vision of delivering cutting-edge healthcare solutions.